Trial Profile
BCG vs. Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer: A Randomized Prospective Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Apr 2010
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; BCG
- Indications Bladder cancer
- Focus Therapeutic Use
- 09 Jul 2008 New trial record.